Malignant Oropharyngeal Neoplasm — Trials

Malignant Oropharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

461 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 143
Recruiting: 77
Ph III recruiting: 7
Growth YoY: −7.7%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (67)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05787535	HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor	unknown	Phase 1	17	HRYZ Biotech Co.INDUSTRY	1	Feb 2, 2024	clinicaltrials
NCT03874572	Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth(MESRIX-SAFETY)	unknown	Phase 1	10	Rigshospitalet, DenmarkOTHER	1	Jan 29, 2021	clinicaltrials